UNCOVERED: 7 - Caught on Camera

Study finds taxi and ambulance drivers less likely to die from Alzheimer's disease

A new study published in the British Medical Journal has revealed that deaths from Alzheimer’s disease are significantly lower among taxi and ambulance drivers, who frequently engage in processing spatial and navigational information. The findings suggest that these professions may offer a protective effect against Alzheimer’s, a progressive age-related condition…

The Times of India · Dec 17, 2024

These surprising professions have the lowest rate of Alzheimer’s disease deaths

Alzheimer’s disease is a form of dementia and it is one of the leading causes of death in the United States

The Independent UK · Dec 16, 2024

Does menopause hormone therapy increase or decrease your risk of dementia? Here’s the science

By 2050, around 135 million people worldwide will be living with dementia. The most common cause of dementia is Alzheimer’s disease. Women are more likely than men to develop Alzheimer’s disease, even after accounting for women living longer.

The Conversation · Dec 9, 2024

Vulnerability to financial scams in aging adults could be an early indicator of Alzheimer’s disease, new research shows

A brain region affected very early in Alzheimer’s disease may explain why some aging people are at greater risk of financial exploitation. That is the key finding of our new study, published in the journal Cerebral Cortex.

The Conversation · Nov 22, 2024

Study finds how Alzheimer's disease may damage brain in two phases

Alzheimer's disease may cause brain damage in two stages, according to new research supported by the National Institutes of Health (NIH) that uses sophisticated brain mapping methods. Read further on Dynamite News:

Dynamite News · Nov 22, 2024

Blood test could ‘reliably rule out’ Alzheimer’s, trial finds

There are hopes it will offer reassurance to patients with cognitive decline and help them avoid unnecessary further testing, researchers said.

Evening Standard · Oct 31, 2024

Alzheimer’s drug approved in the UK, but it won’t be available on the NHS – here’s why

The UK’s drugs regulator – the MHRA – has approved the Alzheimer’s drug donanemab, but it won’t be available on the NHS.

The Conversation · Oct 28, 2024

Fell for a Financial Scam? Might Be Time to Test for Alzheimer's

Falling for financial scams may be an early indicator of Alzheimer's among older adults.

Kiplinger · Oct 26, 2024

Ozempic Outperformed 7 Diabetes Medications in Reducing the Risk for Alzheimer’s Disease

Semaglutide outperformed 7 diabetes medications in reducing risk of Alzheimer's disease, according to a study of over 1 million patients with type 2 diabetes.

Inverse · Oct 25, 2024

Alzheimer's 'wonder drug' Donanemab blocked for use on NHS over cost concerns

Campaigners say decision is ‘frustrating setback’ for people living with disease

Evening Standard · Oct 23, 2024